{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:07:37Z","timestamp":1789884457896,"version":"4.0.1"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Lipoprotein lipase (LPL) plays a crucial role in preventing dyslipidemia by hydrolyzing triglycerides (TGs) in packaged lipoproteins. Since hypertriglyceridemia (HTG) is a major risk factor for cardiovascular disease (CVD), the leading cause of death worldwide, methods that accurately quantify the hydrolytic activity of LPL in clinical and pre-clinical samples are much needed. To date, the methods used to determine LPL activity vary considerably in their approach, in the LPL substrates used, and in the source of LPL activators and inhibitors used to quantify LPL-specific activity, rather than other lipases, e.g., hepatic lipase (HL) or endothelial lipase (EL) activity. Here, we describe methods recently optimized in our laboratory, using a synthetic ApoC-II peptide to activate LPL, and an n-terminal Angiopoietin-Like 4 fragment (nAngptl4) to inhibit LPL, presenting a cost-effective and reproducible method to measure LPL activity in human post-heparin plasma (PHP) and in LPL-enriched heparin released (HR) fractions from LPL secreting cells. We also describe a modified version of the triolein-based assay using human serum as a source of endogenous activators and inhibitors and to determine the relative abundance of circulating factors that regulate LPL activity. Finally, we describe how an ApoC-II peptide and nAngptl4 can be applied to high-throughput measurements of LPL activity using the EnzChek\u2122 fluorescent TG analog substrate with PHP, bovine LPL, and HR LPL enriched fractions. In summary, this manuscript assesses the current methods of measuring LPL activity and makes new recommendations for measuring LPL-mediated hydrolysis in pre-clinical and clinical samples.<\/jats:p>","DOI":"10.3389\/fcvm.2022.926631","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T04:54:16Z","timestamp":1657774456000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Using Synthetic ApoC-II Peptides and nAngptl4 Fragments to Measure Lipoprotein Lipase Activity in Radiometric and Fluorescent Assays"],"prefix":"10.3389","volume":"9","author":[{"given":"Dean","family":"Oldham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Lietzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Sprenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Reigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Eckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley D.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1126\/science.120.3114.399-a","article-title":"Properties of clearing factor obtained from rat heart acetone powder.","volume":"120","author":"Korn","year":"1954","journal-title":"Science."},{"key":"B2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0021-9258(18)66012-0","article-title":"Clearing factor, a heparin-activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil.","volume":"215","author":"Korn","year":"1955","journal-title":"J Biol Chem."},{"key":"B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9258(18)66011-9","article-title":"Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart.","volume":"215","author":"Korn","year":"1955","journal-title":"J Biol Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bbalip.2014.03.013","article-title":"Physiological regulation of lipoprotein lipase.","volume":"1841","author":"Kersten","year":"2014","journal-title":"Biochim Biophys Acta."},{"key":"B5","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1001\/jama.2017.0972","article-title":"Myocardial infarction genetics consortium DSGCEC, global lipids genetics c. association of rare and common variation in the lipoprotein lipase gene with coronary artery disease.","volume":"317","author":"Khera","year":"2017","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1056\/NEJMoa1507652","article-title":"Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease.","volume":"374","author":"Myocardial Infarction","year":"2016","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218338","article-title":"Genetic variants of lipoprotein lipase and regulatory factors associated with Alzheimer\u2019s disease risk.","volume":"21","author":"Db","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/MOL.0b013e32833854c0","article-title":"Lipase maturation factor 1: structure and role in lipase folding and assembly.","volume":"21","author":"Doolittle","year":"2010","journal-title":"Curr Opin Lipidol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.cmet.2014.06.015","article-title":"The ER-associated degradation adaptor protein Sel1L regulates LPL secretion and lipid metabolism.","volume":"20","author":"Sha","year":"2014","journal-title":"Cell Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"8934","DOI":"10.1074\/jbc.M008813200","article-title":"Transcytosis of lipoprotein lipase across cultured endothelial cells requires both heparan sulfate proteoglycans and the very low density lipoprotein receptor.","volume":"276","author":"Obunike","year":"2001","journal-title":"J Biol Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.cmet.2014.01.017","article-title":"The GPIHBP1-LPL complex is responsible for the margination of triglyceride-rich lipoproteins in capillaries.","volume":"19","author":"Goulbourne","year":"2014","journal-title":"Cell Metab."},{"key":"B12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1365-2796.2012.02516.x","article-title":"Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.","volume":"272","author":"Surendran","year":"2012","journal-title":"J Intern Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"15747","DOI":"10.1074\/jbc.M110.217638","article-title":"Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity.","volume":"286","author":"Lei","year":"2011","journal-title":"J Biol Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage.","volume":"101","author":"Backhed","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1161\/01.RES.0000250758.63358.91","article-title":"Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton.","volume":"99","author":"Cazes","year":"2006","journal-title":"Circ Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"11766","DOI":"10.1073\/pnas.0705041104","article-title":"Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice.","volume":"104","author":"Desai","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tem.2013.12.005","article-title":"Regulation of lipoprotein lipase by Angptl4.","volume":"25","author":"Dijk","year":"2014","journal-title":"Trends Endocrinol Metab."},{"key":"B18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/MOL.0000000000000600","article-title":"New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk.","volume":"30","author":"Kersten","year":"2019","journal-title":"Curr Opin Lipidol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.molmed.2019.05.010","article-title":"ANGPTL4 in metabolic and cardiovascular disease.","volume":"25","author":"Aryal","year":"2019","journal-title":"Trends Mol Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1073\/pnas.1920202117","article-title":"Unfolding of monomeric lipoprotein lipase by ANGPTL4: Insight into the regulation of plasma triglyceride metabolism.","volume":"117","author":"Kristensen","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1074\/jbc.RA118.005932","article-title":"Mapping the sites of the lipoprotein lipase (LPL)-angiopoietin-like protein 4 (ANGPTL4) interaction provides mechanistic insight into LPL inhibition.","volume":"294","author":"Gutgsell","year":"2019","journal-title":"J Biol Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1046\/j.1432-1033.2002.03179.x","article-title":"Molecular modeling of the dimeric structure of human lipoprotein lipase and functional studies of the carboxyl-terminal domain.","volume":"269","author":"Kobayashi","year":"2002","journal-title":"Eur J Biochem."},{"key":"B23","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1016\/S0021-9258(17)41822-9","article-title":"Lipoprotein lipase. Molecular model based on the pancreatic lipase x-ray structure: consequences for heparin binding and catalysis.","volume":"269","author":"van Tilbeurgh","year":"1994","journal-title":"J Biol Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5594","DOI":"10.1073\/pnas.94.11.5594","article-title":"A molecular biology-based approach to resolve the subunit orientation of lipoprotein lipase.","volume":"94","author":"Wong","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B25","doi-asserted-by":"publisher","first-page":"17450","DOI":"10.1073\/pnas.0604026103","article-title":"Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue.","volume":"103","author":"Sukonina","year":"2006","journal-title":"Proc Natl Acad Sci U \\SA."},{"key":"B26","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.1073\/pnas.1900983116","article-title":"Lipoprotein lipase is active as a monomer.","volume":"116","author":"Beigneux","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1073\/pnas.74.11.4848","article-title":"Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II.","volume":"74","author":"Kinnunen","year":"1977","journal-title":"Proc Natl Acad Sci USA."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1056\/NEJM197806082982301","article-title":"Hypertriglyceridemia associated with deficiency of apolipoprotein C-II.","volume":"298","author":"Breckenridge","year":"1978","journal-title":"N Engl J Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1210\/jc.2016-3903","article-title":"A novel APOC2 missense mutation causing apolipoprotein C-II deficiency with severe triglyceridemia and pancreatitis.","volume":"102","author":"Ueda","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"B30","first-page":"249","article-title":"Chylomicronemia syndrome.","volume":"37","author":"Chait","year":"1992","journal-title":"Adv Intern Med."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129488","article-title":"Genetic variants associated with gestational hypertriglyceridemia and pancreatitis.","volume":"10","author":"Xie","year":"2015","journal-title":"PLoS One."},{"key":"B32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/s0021-9150(96)06061-3","article-title":"A G+1 to C mutation in a donor splice site of intron 2 in the apolipoprotein (apo) C-II gene in a patient with apo C-II deficiency. A possible interaction between apo C-II deficiency and apo E4 in a severely hypertriglyceridemic patient.","volume":"130","author":"Okubo","year":"1997","journal-title":"Atherosclerosis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2017.10.025","article-title":"Apolipoprotein C-II: new findings related to genetics, biochemistry, and role in triglyceride metabolism.","volume":"267","author":"Wolska","year":"2017","journal-title":"Atherosclerosis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"13891","DOI":"10.1074\/jbc.M110.179572","article-title":"Macrophage-specific up-regulation of apolipoprotein E gene expression by STAT1 is achieved via long range genomic interactions.","volume":"286","author":"Trusca","year":"2011","journal-title":"J Biol Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"31900","DOI":"10.1074\/jbc.M202993200","article-title":"Regulated expression of the apolipoprotein E\/C-I\/C-IV\/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta.","volume":"277","author":"Mak","year":"2002","journal-title":"J Biol Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1124\/jpet.114.220418","article-title":"A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice.","volume":"352","author":"Amar","year":"2015","journal-title":"J Pharmacol Exp Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"7484","DOI":"10.1074\/jbc.M109.022046","article-title":"Site-directed mutagenesis of apolipoprotein CII to probe the role of its secondary structure for activation of lipoprotein lipase.","volume":"285","author":"Shen","year":"2010","journal-title":"J Biol Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"30979","DOI":"10.1074\/jbc.273.47.30979","article-title":"Subdomain chimeras of hepatic lipase and lipoprotein lipase. Localization of heparin and cofactor binding.","volume":"273","author":"Hill","year":"1998","journal-title":"J Biol Chem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1074\/jbc.M105421200","article-title":"Functional analyses of human apolipoprotein CII by site-directed mutagenesis: identification of residues important for activation of lipoprotein lipase.","volume":"277","author":"Shen","year":"2002","journal-title":"J Biol Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.amjmed.2021.03.014","article-title":"Mechanistic insights from REDUCE-IT STRENGTHen the case against triglyceride lowering as a strategy for cardiovascular disease risk reduction.","volume":"134","author":"Mason","year":"2021","journal-title":"Am J Med."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0706-1","article-title":"The impact of lipoprotein lipase deficiency on health-related quality of life: a detailed, structured, qualitative study.","volume":"12","author":"Neelamekam","year":"2017","journal-title":"Orphanet J Rare Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1210\/jcem.85.9.6816","article-title":"Seasonal variation in lipoprotein lipase and plasma lipids in physically active, normal weight humans.","volume":"85","author":"Donahoo","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"B43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2337\/diacare.26.3.557","article-title":"Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults.","volume":"26","author":"Duncan","year":"2003","journal-title":"Diabetes Care."},{"key":"B44","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0022-2275(20)30466-1","article-title":"Characterization of the lipolytic activity of endothelial lipase.","volume":"43","author":"McCoy","year":"2002","journal-title":"J Lipid Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/s1043-2760(02)00589-1","article-title":"Lipases and HDL metabolism.","volume":"13","author":"Jin","year":"2002","journal-title":"Trends Endocrinol Metab."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1194\/jlr.D700021-JLR200","article-title":"Appraisal of hepatic lipase and lipoprotein lipase activities in mice.","volume":"48","author":"Dallinga-Thie","year":"2007","journal-title":"J Lipid Res."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.593931","article-title":"A comprehensive update on the chylomicronemia syndrome.","volume":"11","author":"Goldberg","year":"2020","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2021.02.020","article-title":"A novel GPIHBP1 mutation related to familial chylomicronemia syndrome: a series of cases.","volume":"322","author":"Lima","year":"2021","journal-title":"Atherosclerosis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1194\/jlr.M077313","article-title":"The apolipoprotein C-III (Gln38Lys) variant associated with human hypertriglyceridemia is a gain-of-function mutation.","volume":"58","author":"Sundaram","year":"2017","journal-title":"J Lipid Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jacl.2021.03.006","article-title":"Novel PPARG mutation in multiple family members with chylomicronemia.","volume":"15","author":"Glodowski","year":"2021","journal-title":"J Clin Lipidol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140989","article-title":"Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice.","volume":"131","author":"Singh","year":"2021","journal-title":"J Clin Invest."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-0351-6","article-title":"Dual apoC-II mimetic and apoC-III antagonist for hypertriglyceridaemia.","volume":"17","author":"Huynh","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw7905","article-title":"A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides.","volume":"12","author":"Wolska","year":"2020","journal-title":"Sci Transl Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1194\/jlr.D010744","article-title":"Determination of lipoprotein lipase activity using a novel fluorescent lipase assay.","volume":"52","author":"Basu","year":"2011","journal-title":"J Lipid Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2337\/diab.26.1.11","article-title":"Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.","volume":"26","author":"Nikkila","year":"1977","journal-title":"Diabetes."},{"key":"B56","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0009-8981(75)90055-8","article-title":"An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma.","volume":"63","author":"Huttunen","year":"1975","journal-title":"Clin Chim Acta."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1194\/jlr.M700528-JLR200","article-title":"A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma.","volume":"49","author":"Imamura","year":"2008","journal-title":"J Lipid Res."},{"key":"B58","doi-asserted-by":"crossref","first-page":"10720","DOI":"10.1016\/S0021-9258(19)85142-6","article-title":"Purification and characterization of human lipoprotein lipase and hepatic triglyceride lipase. Reactivity with monoclonal antibodies to hepatic triglyceride lipase.","volume":"260","author":"Cheng","year":"1985","journal-title":"J Biol Chem."},{"key":"B59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0022-2275(20)36976-5","article-title":"Measurement of two plasma triglyceride lipases by an immunochemical method: studies in patients with hypertriglyceridemia.","volume":"17","author":"Greten","year":"1976","journal-title":"J Lipid Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/ejhg.2009.61","article-title":"Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes.","volume":"17","author":"van Hoek","year":"2009","journal-title":"Eur J Hum Genet."},{"key":"B61","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1042\/cs0500249","article-title":"Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism.","volume":"50","author":"Huttunen","year":"1976","journal-title":"Clin Sci Mol Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"28524","DOI":"10.1074\/jbc.M113.497602","article-title":"Angiopoietin-like protein 4 inhibition of lipoprotein lipase: evidence for reversible complex formation.","volume":"288","author":"Lafferty","year":"2013","journal-title":"J Biol Chem."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-021-01580-z","article-title":"Circulating ANGPTL3 and ANGPTL4 levels predict coronary artery atherosclerosis severity.","volume":"20","author":"Sun","year":"2021","journal-title":"Lipids Health Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2337\/diab.32.6.525","article-title":"The response of plasma triglyceride, cholesterol, and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridemia.","volume":"32","author":"Pfeifer","year":"1983","journal-title":"Diabetes."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099721","article-title":"Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects.","volume":"9","author":"Di Filippo","year":"2014","journal-title":"PLoS One."},{"key":"B66","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1016\/S0021-9258(19)39557-2","article-title":"Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.","volume":"265","author":"Goldberg","year":"1990","journal-title":"J Biol Chem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1373\/clinchem.2008.108175","article-title":"High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance.","volume":"54","author":"Hortin","year":"2008","journal-title":"Clin Chem."},{"key":"B68","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-2275(20)41540-8","article-title":"Preheparin lipoprotein lipolytic activities: relationship to plasma lipoproteins and postheparin lipolytic activities.","volume":"33","author":"Glaser","year":"1992","journal-title":"J Lipid Res."},{"key":"B69","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0022-2275(20)38302-4","article-title":"p-nitrophenyl butyrate hydrolyzing activity of hormone-sensitive lipase from bovine adipose tissue.","volume":"30","author":"Tsujita","year":"1989","journal-title":"J Lipid Res."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2021.100115","article-title":"A simple, rapid, and sensitive fluorescence-based method to assess triacylglycerol hydrolase activity.","volume":"62","author":"Rajan","year":"2021","journal-title":"J Lipid Res."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87020-5","article-title":"Regulation of plasma triglyceride partitioning by adipose-derived ANGPTL4 in mice.","volume":"11","author":"Spitler","year":"2021","journal-title":"Sci Rep."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.bmcl.2014.03.021","article-title":"A novel Lipoprotein lipase (LPL) agonist rescues the enzyme from inhibition by angiopoietin-like 4 (ANGPTL4).","volume":"24","author":"Geldenhuys","year":"2014","journal-title":"Bioorg Med Chem Lett."},{"key":"B73","doi-asserted-by":"publisher","first-page":"W365","DOI":"10.1093\/nar\/gkx407","article-title":"HDOCK: a web server for protein-protein and protein-DNA\/RNA docking based on a hybrid strategy.","volume":"45","author":"Yan","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics.","volume":"14","author":"Humphrey","year":"1996","journal-title":"J Mol Graph."},{"key":"B75","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","article-title":"Highly accurate protein structure prediction for the human proteome.","volume":"596","author":"Tunyasuvunakool","year":"2021","journal-title":"Nature."},{"key":"B76","year":"","journal-title":"Lipoprotein Lipase (Human). AlphaFold Structure Prediction P06858."},{"key":"B77","year":"","journal-title":"Apolipoprotein C-II (Human). AlphaFold Structure Prediction.P02655."},{"key":"B78","year":"","journal-title":"Angiopoietin-Related Protein 4 (mus musculus). AlphaFold Structure Prediction.Q9Z1P8."},{"key":"B79","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/0005-2760(78)90004-8","article-title":"Metabolic fate of the phosphatidylcholine component of very low density lipoproteins during catabolism by the perfused rat heart.","volume":"530","author":"Groot","year":"1978","journal-title":"Biochim Biophys Acta."},{"key":"B80","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/0005-2760(76)90219-8","article-title":"Hydrolysis of chylomicron phosphatidylcholine in vitro by lipoprotein lipase, phospholipase A2 and phospholipase C.","volume":"431","author":"Scow","year":"1976","journal-title":"Biochim Biophys Acta."},{"key":"B81","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/BF02540967","article-title":"Activation of the phospholipase A1 activity of lipoprotein lipase by apoprotein C-II.","volume":"15","author":"Stocks","year":"1980","journal-title":"Lipids."},{"key":"B82","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0021-9258(19)68183-4","article-title":"Lipoprotein lipase-catalyzed hydrolysis of p-nitrophenyl butyrate. Interfacial activation by phospholipid vesicles.","volume":"257","author":"Shirai","year":"1982","journal-title":"J Biol Chem."},{"key":"B83","doi-asserted-by":"crossref","first-page":"10200","DOI":"10.1016\/S0021-9258(18)34004-3","article-title":"Reciprocal effect of apolipoprotein C-II on the lipoprotein lipase-catalyzed hydrolysis of p-nitrophenyl butyrate and trioleoylglycerol.","volume":"257","author":"Shirai","year":"1982","journal-title":"J Biol Chem."},{"key":"B84","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0005-2760(73)90215-4","article-title":"Purified bovine milk (lipoprotein) lipase: activity against lipid substrates in the absence of exogenous serum factors.","volume":"306","author":"Egelrud","year":"1973","journal-title":"Biochim Biophys Acta."},{"key":"B85","doi-asserted-by":"publisher","first-page":"6872","DOI":"10.1021\/bi00269a038","article-title":"Lipoprotein lipase catalyzed hydrolysis of water-soluble p-nitrophenyl esters. Inhibition by apolipoprotein C-II.","volume":"21","author":"Quinn","year":"1982","journal-title":"Biochemistry."},{"key":"B86","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0022-2275(20)37584-2","article-title":"New fluorogenic triacylglycerol analogs as substrates for the determination and chiral discrimination of lipase activities.","volume":"37","author":"Duque","year":"1996","journal-title":"J Lipid Res."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.926631\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T04:54:27Z","timestamp":1657774467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.926631\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":86,"alternative-id":["10.3389\/fcvm.2022.926631"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.926631","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"article-number":"926631"}}